期刊文献+

盐酸地尔硫Polyox-WSR亲水凝胶骨架片的研究 被引量:3

Study on compressed hydrophilic matrices tablets of Polyox-WSR
下载PDF
导出
摘要 目的研究亲水性树脂Polyox WSR为凝胶缓释骨架的性能。方法以盐酸地尔硫为模型药物 ,采用粉末直接压片工艺制备亲水凝胶骨架片 ,考察影响骨架片释放度的因素和释药模型。结果Polyox WSR的黏度和用量、润滑剂的种类、压片粉末含水量对骨架片的释放度有影响 ;体外释放度显示骨架片的释放较接近零级方程和Higuchi方程。结论用Polyox Objective To investigate the release performance of gel matrices sustained release tablets based on hydrophilic resin Polyox-WSR. Methods The hydrophilic gel matrices sustained release tablets containing diltiazem hydrochlride as a model drug were obtained by direct compression method. The effects of release and release model were observed. Results The content and the viscosity of Polyox-WSR, the kind of lubricants, and the moisture content of the direct compression powder can influence the release of diltiazem hydrochlride from matrix tablets.The drug release pattern from the matrix tablets was approach to Higuchi and zero-order equation. Conclusion The Polyox-WSR can be used as a barrier to prepare a hydrophilic gel matrices sustained release tablets.
出处 《广东药学院学报》 CAS 2004年第6期599-601,609,共4页 Academic Journal of Guangdong College of Pharmacy
关键词 Polyox-WSR 直接压片 亲水凝胶 骨架片 Polyox-WSR Direct compressed Hydrophilic Matrices Tablets
  • 相关文献

参考文献6

  • 1USP27-NF22(S2):2913. 被引量:1
  • 2USP27-NF22(S2):628. 被引量:1
  • 3Apicella A, Cappeilo B, DeiNobile M A, et al. Poly(ethylene oxide)(PEO) and different molecular weight PEO blends monolithic derives for drug release[J]. Biomaterials,1993,14(2):83. 被引量:1
  • 4Kim C J. Drug Release from Compressed Hydrophilic POLYOX-WSR Tablets[J]. Journal of Pharmaceutical Sciences, 1995,84(3):303. 被引量:1
  • 5Yang L,Johnson B,Fassihi R. Determination of continuous changes in the gel layer thickness of poly(ethylene oxide) and HPMC tablets undergoing hydration: a texture analysis study[J]. Pharm Res, 1998,15(12): 1902. 被引量:1
  • 6Pillay V, Fassihi R A novel approach for constant rate delivery of highly soluble bioactives from a simple monolithic system[J]. J Control Release,2000,67(1):67. 被引量:1

同被引文献29

  • 1董志超,蒋雪涛.羟丙基甲基纤维素的性质对药物亲水性骨架片溶出度的影响[J].药学学报,1994,29(12):920-924. 被引量:61
  • 2黄胜炎.心血管药物新制剂[J].上海医药,2005,26(9):399-402. 被引量:5
  • 3董志超,蒋雪涛.羟丙基甲基纤维素在凝胶骨架中的含量与水溶性药物释放机制的关系[J].药学学报,1996,31(1):43-47. 被引量:31
  • 4刘艳,黄卓明,杨亚军,张丹,刘伟,何仲贵.盐酸地尔硫卓缓释片的制备及释药因素考察[J].沈阳药科大学学报,2007,24(8):457-460. 被引量:7
  • 5国家药典委员会.国家药品标准:第51册[S]//盐酸地尔硫卓缓释片药品标准[WS1-(X-052)-2004Z].北京:人民卫生出版社,2006:196-197. 被引量:1
  • 6MOORE J W,FLANNER H H.Mathematical comparison of dissolution profiles[J].Pharm Tech,1996,20(6):64-74. 被引量:1
  • 7HUANG Ye,KHANVILKAR K H,MOORE A D,et al.Effects of Manufacturing process variables on in vitro dissolution characueristics of extended-release tablets formulated with hydroxypropyl methylcellulose[J].Drug Dev Ind Pharm,2003,29(1):79-88. 被引量:1
  • 8David Awotwe-Otoo,Cyrus Agarabi,Geoffrey K. Wu,Elizabeth Casey,Erik Read,Scott Lute,Kurt A. Brorson,Mansoor A. Khan,Rakhi B. Shah.Quality by design: Impact of formulation variables and their interactions on quality attributes of a lyophilized monoclonal antibody[J].International Journal of Pharmaceutics (-).2012(1-2) 被引量:1
  • 9Dhananjay S. Singare,Seshasai Marella,K. Gowthamrajan,Giriraj T. Kulkarni,Rajesh Vooturi,Parchuri Srinivasa Rao.Optimization of formulation and process variable of nanosuspension: An industrial perspective[J].International Journal of Pharmaceutics.2010(1) 被引量:1
  • 10Jelena Petrovi?,Svetlana Ibri?,Gabriele Betz,Jelena Paroj?i?,Zorica ?uri?.Application of dynamic neural networks in the modeling of drug release from polyethylene oxide matrix tablets[J].European Journal of Pharmaceutical Sciences.2009(2) 被引量:1

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部